Skip to content
Disclosery

13F-HR filed by Rosalind Advisors, Inc.

Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-11, with 40 holding rows worth $195,582,874.

Accession
0001622627-25-000008
Filer
CIK 1622627
Filed
2025-02-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 40 entries on the cover page, a total value of $195,582,874 stated on the cover page (in dollars after the unit check, H1), rows summing to $195,582,874 with VALUE read as dollars as filed, 13F file number 028-23857. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DELCATH SYSTEMS INC24661P807COMMON STOCK2,650,389$31,910,684dollars as filed
MYOMO INC62857J201COM NEW2,998,945$19,313,206dollars as filed
MEDIWOUND LTDM68830112COMMON STOCK628,050$11,179,290dollars as filed
CHIMERIX INC COM16934W106Stock3,050,000$10,614,000dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM3,104,995$10,525,933dollars as filed
ABEONA THERAPEUTICS INC00289Y206COM NEW1,805,390$10,056,022dollars as filed
OCULAR THERAPEUTIX INC67576A100COM1,128,700$9,639,098dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK870,000$9,265,500dollars as filed
SAVARA INC805111101COM2,654,944$8,150,678dollars as filed
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK1,259,876$7,962,416dollars as filed
CYBIN INC23256X407COM NEW810,918$7,152,297dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS150,000$6,966,000dollars as filed
INSPIREMD INC45779A846COM2,495,783$6,563,909dollars as filed
OPTINOSE INC68404V209COM876,996$5,858,333dollars as filed
PROFOUND MED CORP74319B502COM NEW692,185$5,198,309dollars as filed
VERASTEM INC92337C203COMMON STOCK900,000$4,653,000dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock1,062,500$4,377,500dollars as filed
FILANA THERAPEUTICS INC14817C957COM417,400$3,650,360dollars as filedput
REPLIMUNE GROUP INC76029N106COMMON STOCK260,000$3,148,600dollars as filed
POLYPID LTDM8001Q126COM1,022,521$3,108,464dollars as filed
BIOMEA FUSION INC09077A956COM910,700$2,763,790dollars as filedput
COMPASS PATHWAYS PLC20451W101SPONSORED ADS707,625$2,674,823dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM303,864$2,573,728dollars as filed
ALPHA COGNITION INC02074J501COM NEW252,753$1,488,715dollars as filed
FILANA THERAPEUTICS INC14817C107CMN417,400$985,064dollars as filed
CORMEDIX INC21900C908COM183,900$919,500dollars as filedcall
BIOFRONTERA INC09077D209COM NEW811,918$884,991dollars as filed
KIORA PHARMACEUTICALS INC49721T507COM250,555$826,832dollars as filed
EDGEWISE THERAPEUTICS INC28036F955COM237,500$807,500dollars as filedput
ISHARES TR464287955PUT200,000$404,000dollars as filedput
INVESCO QQQ TR46090E953PUT100,000$356,000dollars as filedput
TALPHERA INC00444T209COM NEW613,939$321,765dollars as filed
SPDR SERIES TRUST78464A950PUT800,000$311,000dollars as filedput
NEUMORA THERAPEUTICS INC.640979950COM136,600$300,240dollars as filedput
LEXICON PHARMACEUTICALS INC528872902COM NEW1,278,900$281,835dollars as filedcall
OWLET INC69120X206CL A NEW49,441$220,012dollars as filed
RELMADA THERAPEUTICS INC75955J952COM100,000$95,000dollars as filedput
RELMADA THERAPEUTICS INC75955J402COMMON STOCK100,000$52,000dollars as filed
SPDR SERIES TRUST78464A900ST STR SP BIOT1,400,000$22,000dollars as filedcall
CANDEL THERAPEUTICS INC137404959COM262,500$480dollars as filedput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001622627-25-000008this filing2025-02-11acceptance time not in the bulk data set
13F-HR/A 0001622627-25-000016 base2025-02-14acceptance time not in the bulk data set